Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
71 studies found for:    "Primary biliary cirrhosis"
Show Display Options
Rank Status Study
1 Completed Initial Study of Rituximab to Treat Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Drug: rituximab
2 Completed Moexipril for Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Drug: Moexipril
3 Completed Study of Combivir for Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Combination antiviral therapy;   Drug: Placebo
4 Recruiting Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Intervention: Genetic: Genetic Analysis
5 Withdrawn Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Biological: Non-myeloablative Hematopoietic Stem Cell Transplantation
6 Completed
Has Results
Use of Fenofibrate for Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Drug: Fenofibrate (Insoluble Drug Delivery-Micro Particle Fenofibrate (IDD-P)
7 Active, not recruiting Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Biological: abatacept
8 Recruiting Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Bezafibrate;   Drug: Ursodeoxycholic Acid;   Drug: Placebo (for Bezafibrate)
9 Unknown  Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Other: conventional plus UC-MSC treatment;   Other: Conventional plus placebo treatment
10 Active, not recruiting Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Obeticholic Acid (OCA);   Drug: Placebo
11 Completed Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Tauroursodeoxycholic Acid Capsules;   Drug: Ursodeoxycholic Acid Capsules
12 Completed
Has Results
Pentoxifylline for Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Drug: Pentoxifylline
13 Completed
Has Results
A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid
Condition: Primary Biliary Cirrhosis
Interventions: Drug: ustekinumab 90 mg;   Drug: ustekinumab 45 mg;   Drug: ustekinumab 180 mg;   Drug: Placebo
14 Recruiting The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
Condition: Primary Biliary Cirrhosis
Intervention:
15 Recruiting Interrogating Potential Therapeutic Targets for Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Interventions: Other: Clinic visit;   Other: Baseline visit
16 Completed Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Tetrathiomolybdate;   Other: Placebo
17 Recruiting Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Dietary Supplement: S-adenosyl-L-methionine
18 Completed High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Dietary Supplement: High protein high fiber diet
19 Recruiting Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fenofibrate;   Drug: UDCA
20 Completed Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Drug: Truvada and Kaletra

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.